Consequently, adipose inflammation and obesity are remarkably diminished by all kinds of SSAO inhibitors in obese and diabetic rodent models (Supplementary Table 1) (Papukashvili et al., 2020). This evidence concerns the gene AOC3 and obesity disorder.